Zhang Hui-Zhong, Gao Ping, Yan Lu, Lin Fang
Center of Clinical Research, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, 710038, PR China.
Ai Zheng. 2004 May;23(5):493-6.
BACKGROUND & OBJECTIVE: Stathmin, a signal transduction regulatory factor, plays a crucial role in cell division and malignant tumor development. This study was designed to analyze stathmin gene expression in the tissue of osteosarcoma, and to explore the growth inhibition by blocking stathmin expression with Stathmin antisense oligodeoxynucleotide (ASODN) on cultured human osteosarcoma cell line with stathmin gene overexpression.
Reverse transcriptase polymerase chain reaction (RT-PCR) and in situ hybridization methods were used to determine the expression of stathmin in two human osteosarcoma cell lines and 45 osteosarcoma tissue specimens. Using stathmin gene overexpression in human osteosarcoma cell line SOSP-9607 as target cell and stathmin ASODN as gene expression blocking agent, cell growth inhibition of stathmin ASODN was determined by MTT method, and cell growth and mitotic character was analyzed by flow cytometry.
Both osteosarcoma cell lines of SOSP-9607 and SOSP-9901 showed stathmin gene overexpression by RT-PCR method and 24 of 45 osteosarcoma specimens were stathmin positive by in situ hybridization, while there were only 2 in 10 normal tissues with mild positive signal. There was significant difference in stathmin gene expression between human osteosarcoma tissues and normal tissues (P< 0.05). The growth of osteosarcoma cells were suppressed by ASODN (P< 0.05,P< 0.01). The cell cycle of SOSP-9607 was blocked in metaphase and cell apoptosis was found.
Stathmin gene displays high level expression in osteosarcoma, which may become a new target for the bio-treatment for osteosarcoma.
信号转导调节因子Stathmin在细胞分裂及恶性肿瘤发展过程中起关键作用。本研究旨在分析骨肉瘤组织中Stathmin基因的表达情况,并探讨采用Stathmin反义寡脱氧核苷酸(ASODN)阻断Stathmin表达对具有Stathmin基因过表达的人骨肉瘤细胞系的生长抑制作用。
采用逆转录聚合酶链反应(RT-PCR)及原位杂交方法检测两种人骨肉瘤细胞系及45例骨肉瘤组织标本中Stathmin的表达。以人骨肉瘤细胞系SOSP-9607中Stathmin基因过表达为靶细胞,以Stathmin ASODN作为基因表达阻断剂,采用MTT法检测Stathmin ASODN对细胞生长的抑制作用,采用流式细胞术分析细胞生长及有丝分裂特征。
RT-PCR法显示骨肉瘤细胞系SOSP-9607和SOSP-9901均有Stathmin基因过表达,原位杂交显示45例骨肉瘤标本中有24例Stathmin阳性,而10例正常组织中仅有2例呈轻度阳性信号。人骨肉瘤组织与正常组织中Stathmin基因表达差异有统计学意义(P<0.05)。ASODN可抑制骨肉瘤细胞生长(P<0.05,P<0.01)。SOSP-9607细胞周期阻滞于中期并出现细胞凋亡。
Stathmin基因在骨肉瘤中呈高水平表达,有望成为骨肉瘤生物治疗的新靶点。